甲磺酸达比加群酯

甲磺酸达比加群酯
Hexyl 2-(4-(((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)benzylidene)hydrazinecarboxylate methanesulfonate;Dabigatran etexilate mesylate;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat;Dabigatran Etexilate;Dabigatran etexilate (mesylate);Dabigatran mesylate;Pradaxa;Pradaxa Mesylate;BIBR 1048MS;Dabigatran etexilate methanesulfonate;Prazaxa;MLS006010034;KSGXQBZTULBEEQ-UHFFFAOYSA-N;HMS3655H04;BCP02864;CD0134;SMR004701211;SW219397-1;ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate;1-methyl-[n-[4-(n-n-hexyloxycarbonylamidino)phenyl]aminomethyl]benzimidazol-5-yl-carboxylic acid-n-(2-pyridyl)-n-(2-ethoxycarbonylethyl)amid